학술논문
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial
Document Type
Article
Author
Mc Govern, Eavan; Yazbeck, Elise; Barbier, Magali; Luton, Marie-Pierre; Pousset, Françoise; Hogrel, Jean-Yves; Adanyeguh, Isaac; Then Bergh, Florian; Bergner, Caroline; Unterlauft, Astrid; Roicke, Hannes; Hoffmann, Karl-Titus; Scherlach, Cordula; Kalb, Andrea; Meilick, Bianca; Reuschel, Mandy; Fenu, Silvia; Mauro, Elena; Murphy, Elaine; Krishna, Gauri; Beyene, Tiggy; Sierra, Alba; Quiñoa, Sara; Belen Canovas, Anna; Grosz, Zoltan; Györgyi, Báthori; van de Stadt, S.I.; Huffnagel, I.C.; van Ballegoij, W.J.C.; Voermans, M.M.C.; Seyedsadjadi, Reza; Corre, Camille; Godbole, Neha; Grant, Natalie Rose; Brito Pires, Claudia Maria; Trovato, Melissa; Yeh, Nancy; Goodman, Jordan; Keller, Jennifer; Joseph, Chris; Van Haren, Keith; Sakamuri, Sarada; Duong, Tina; Perrone, Lila; Tran, Stephanie; Dunaway Young, Sally; Hashmi, Syed; Köhler, Wolfgang ; Engelen, Marc; Eichler, Florian; Lachmann, Robin; Fatemi, Ali; Sampson, Jacinda; Salsano, Ettore; Gamez, Josep; Molnar, Maria Judit; Pascual, Sílvia; Rovira, Maria; Vilà, Anna; Pina, Guillem; Martín-Ugarte, Itziar; Mantilla, Adriana; Pizcueta, Pilar; Rodríguez-Pascau, Laura; Traver, Estefania; Vilalta, Anna; Pascual, María; Martinell, Marc; Meya, Uwe; Mochel, Fanny
Source
In The Lancet Neurology February 2023 22(2):127-136
Subject
Language
ISSN
1474-4422